Sanyo dual-cooling freezer provides sample security

Published: 30-Jun-2011
Manufacturing Research & Development

The upright 728l model is ideal for valuable research or clinical samples

Sanyo has expanded its range of dual-cooling -86°C freezers with the launch of the extra-large capacity MDF-U700VX, an upright 728 litre model which provides maximum sample security for valuable research or clinical samples.

With two independent refrigeration systems the dual-cooling freezers maintain a reliable and uniform -86°C ultralow temperature environment. Should one cooling system suffer an unexpected failure, the other circuit will keep irreplaceable samples safely around -70°C until service can be arranged. This freezer design not only protects precious samples but also prevents the inconvenience and expense of out-of-hours call-outs in the event of a failure of one of the refrigeration systems.

The MDF-U700VX has an extra-large capacity of 728 litres without taking up extra space, thanks to its VIP Plus high efficiency vacuum insulation. In addition to reducing energy use, VIP Plus provides typically 24% more storage capacity compared with a conventionally insulated freezer with the same footprint.

This latest dual-cooling unit offers Sanyo’s industry-first intelligent ECO Mode, optimising compressor operation to match the freezer’s running conditions and minimise energy use. Efficient long-term operation of the freezer is facilitated by the filter-less condenser design, which eliminates the need for routine filter cleaning.

The central door-mounted LCD display panel provides intuitive programming of set points and clear confirmation of freezer status. An on-board data logging function allows the operator to easily check recent freezer performance. Other user-friendly design features include comprehensive alarms, a vacuum release port for smooth door opening, and quiet operation.

The MDF-U700VX is certified as a Class IIa Medical Device (93/42/EEC and 2007/47/EC).

See more

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

Read more
For use in high humidity conditions

Trending Articles

  1. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  2. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  3. Abzena and Mabqi announce strategic partnership to offer integrated discovery through development solution This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution
  4. Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Executive with over 20 years of management experience to lead pharmaceutical packaging and delivery systems company

You may also like

Manufacturing

MIR-S100C offers secure operation for cell culture

For use in high humidity conditions
Containment

Sanyo installs first cell processing workstation in US

To be used to advance stem cell and cell therapy research at the University of Alabama at Birmingham
Manufacturing

Sanyo incubator offers uniform culturing environment

Includes optional hydrogen peroxide decontamination system
Manufacturing

Pioneering Peptide-Builder debuts at UEA

Vapourtec kept it local with the first ever installation of their pioneering production Peptide-Builder system taking place at the University of East Anglia (UEA) in Norwich
Manufacturing

Moderna invests $140m to onshore drug product manufacturing and complete US end-to-end mRNA network

Moderna is expanding its Norwood, Massachusetts site to bring drug product manufacturing in-house, creating hundreds of biomanufacturing jobs and establishing full domestic, end-to-end production for its mRNA vaccines and therapeutics by 2027
Sustainability

Free online course introduces fundamentals of SFC

Learn how SFC can improve efficiency and reduce environmental impact
Manufacturing

GEA to showcase Rockwell Automation-Compatible GEA kytero 2000 Single-Use Separator at Automation Fair 2025

As a gold-level OEM member of the Rockwell PartnerNetwork™, GEA is strengthening its collaboration with Rockwell by offering full compatibility between the kytero® 2000 and Rockwell’s latest hardware and software suite
Subscribe now